1Y Annualised Return
▲6.09%
3Y Annualised Return
▲16.19%
5Y Annualised Return
▲34.68%
Sakar Healthcare Stock Performance
|
|
|
Sakar Healthcare Company background
Founded in: 2004
Managing director: Sanjay S Shah.
Sakar Healthcare Limited was incorporated as a Private Limited Company under the name Sakar Healthcare Private Limited on 26th March 2004. Subsequently, the Company was converted into Public Limited Company on March 27, 2015 and the name of the Company was changed to Sakar Healthcare Limited. The Company is promoted by Sanjay Shah, Rita Shah and Aarsh Shah.The Company is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectables (SVP) in Ampoules and Vials Lyophilized Injections and Oral Solid Dossages. It manufactures and markets pharmaceutical formulations relating to analgesics, anti coagulants, anti malarial, anti spasmodic, antianemics, antibiotics, antiemetics, antihistamines, bronchodilators, corticosteroids, cough and cold preparations, multivitamins, etc.The Company operates as contract development and manufacturing organisation (CDMO), being the EU GMP approved CMO for leading multinational pharmaceutical companies.Their 4 manufacturing facilities located at Changodar, Ahmedabad, Gujarat. have been approved by various international regulatory authorities and certified by ISO 9001:2008 (BVQI), WHOGMP, CGMP National Drug Authority, and it has obtained certain drug specific registrations from the relevant authorities in countries such as Uganda, Kenya, Yemen, Ethiopia, Congo, Ghana, Zimbabwe, Namibia, Nigeria, Cote divoire.In 2005, the Company started commercial production for Plant 1 which was established for production of Liquid Orals in 2007, it started exporting its products overseas started commercial production for Plant 2 which was established for production of Beta Lactum Tablet and Capsules and Dry Syrup Blactum. / Sachet in 2008. Further, it started commercial production for Plant 3 which was established for production of Liquid Injectibles (SVP) Ampoules and Liquid Injectibles (SVP) Vials.In 2012, it started commercial production for Plant 4 which was established for production of Dry Powder Injection. In 2017, it started Lyophilised injection product commercialisation.In 2020, the Company received EU GMP certification for SVP unit manufacturing liquid and Lyophilised injections. In 2021, the Oncology Unit started operations in Bavla location. In 202223, the Company started commercialization with Oncology product post receiving WHO GMP certification.
Sakar Healthcare Financial Highlights
Sakar Healthcare reported a Q2 FY 2025-26
revenue of ₹57.56 crore,
up 14.3% YoY,
with net profit increased
50.0% to ₹4.54 crore. For the full year FY2025–2026, revenue
reached ₹178.9 crore and profit touched at
₹17.5 crore.
Sakar Healthcare Share Price Today
As of 21 Nov 2025, Sakar Healthcare share price is ₹391.5. The stock opened at ₹397.6 and had closed at ₹397.6 the previous day. During today’s trading session, Sakar Healthcare share price moved between ₹387.20 and ₹400.45, with an average price for the day of ₹393.82. Over the last 52 weeks, the stock has recorded a low of ₹210.10 and a high of ₹411.80. In terms of performance, Sakar Healthcare share price has increased by 26.2% over the past six months and has increased by 6.09% over the last year.
Sakar Healthcare SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹3,00,000
Monthly SIP of ₹5,000 would have become ₹8,05,627 in 5 years with a gain of ₹5,05,627 (+168.54%)
Sakar Healthcare Fundamental
Market Cap (in crs)
871.08
Face Value
10
Turnover (in lacs)
49.95
Key Metrics
Qtr Change %
Near 52W High of ₹411.80
23.5
Dividend yield 1yr %
0
Sakar Healthcare Key Financials
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Sakar Healthcare Quarterly Revenue
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
57.56 Cr | 52.74 Cr | 50.24 Cr | 43.42 Cr | 42.78 Cr |
Sakar Healthcare Yearly Revenue
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
178.9 Cr | 156.53 Cr | 138.03 Cr | 130.4 Cr | 95.91 Cr | 85 Cr |
Sakar Healthcare Quarterly Net Profit/Loss
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
4.54 Cr | 4.67 Cr | 5.76 Cr | 4.53 Cr | 4.8 Cr |
Sakar Healthcare Yearly Net Profit/Loss
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
17.5 Cr | 11.67 Cr | 12.76 Cr | 15.18 Cr | 10.68 Cr | 9.62 Cr |
Sakar Healthcare Result Highlights
Result Summary
-
Sakar Healthcare Ltd reported a 10.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 36.2%.
-
Its expenses for the quarter were up by 11.9% QoQ and 40.4% YoY.
-
The net profit decreased 2.8% QoQ and decreased 5.4% YoY.
-
The earnings per share (EPS) of Sakar Healthcare Ltd stood at 2.03 during Q2 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Sakar Healthcare Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
391.5
Current Price
Day EMA5
396.60
Day EMA10
393.50
Day EMA12
391.70
Day EMA20
384.70
Day EMA26
380.40
Day EMA50
368.60
Day EMA100
353.00
Day EMA200
335.90
Day SMA5
398.40
Day SMA10
396.90
Day SMA20
380.30
Day SMA30
373.50
Day SMA50
364.40
Day SMA100
353.20
Day SMA150
339.60
Day SMA200
316.70
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 7847 Rs | 12758 Rs |
Week Rs | 10070 Rs | 14735 Rs |
Month Rs | 21840 Rs | 35278 Rs |
Resistance & Support
393.05
Pivot
Resistance
First Resistance
398.90
Second Resistance
406.30
Third Resistance
412.15
Support
First Support
385.65
Second support
379.80
Third Support
372.40
Relative Strength Index
56.57
Money Flow Index
85.90
MACD
11.22
MACD Signal
10.46
Average True Range
16.73
Average Directional Index
41.73
Rate of Change (21)
7.27
Rate of Change (125)
26.80
Sakar Healthcare Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
689.10 | 921.12 | 270.25 | 707.05 | 644.85 | 22.27% | 51.75% | 106.47% | 134.63% | 252.93% | 0.00% | 14.80 | 41.60 | 1.48 | |
1,391.80 | 860.13 | 957 | 2077.45 | 1,355.80 | -2.42% | -9.43% | 6.10% | -22.18% | -22.84% | 0.13% | 54.51 | 41.60 | 2.93 | |
1,945.20 | 918.46 | 635 | 1971.25 | 1,905.75 | 14.23% | 18.67% | 172.59% | 180.51% | 57.83% | 0.04% | 31.78 | 41.60 | 5.83 | |
954.50 | 990.41 | 596.05 | 1235 | 953.65 | -1.74% | 8.42% | -0.08% | 9.61% | 180.49% | 0.00% | 20.18 | 41.60 | 3.40 | |
727.20 | 856.93 | 630 | 1385 | 729.95 | -4.85% | 6.95% | -29.83% | -38.28% | 0.00% | 0.21% | 43.39 | 41.60 | 3.54 | |
156.32 | 830.86 | 90.78 | 165.4 | 158.95 | 9.80% | 24.43% | 0.00% | 0.00% | 0.00% | 0.00% | 39.94 | 42.32 | 4.07 |
Sakar Healthcare Share Price FAQs
How has Sakar Healthcare shares performed in the past ?
Sakar Healthcare share price in the past 1-year return was 33.2. The Sakar Healthcare share hit a 1-year low of Rs. 210.1 and a 1-year high of Rs. 411.8.
What is the market cap of Sakar Healthcare ?
The market cap of Sakar Healthcare is Rs. 871.08 Cr. as of 20/11/2025.
What is the current P/E ratio of Sakar Healthcare ?
The PE ratios of Sakar Healthcare is 44.54 as of 20/11/2025.
What is the current PB ratio of Sakar Healthcare ?
The PB ratios of Sakar Healthcare is 2.87 as of 20/11/2025
How to buy Sakar Healthcare shares?
You can easily buy Sakar Healthcare shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Sakar Healthcare ?
The 52-week high and low of Sakar Healthcare share price is ₹411.8 and ₹210.1 as of 20/11/2025.
What is the EPS of Sakar Healthcare ?
The earnings per share (EPS) of Sakar Healthcare stood at 2.03 during Q2 FY 2025-26.
Please be aware that Sakar Healthcare stock prices are subject to continuous fluctuations due to various factors.
Invest in Sakar Healthcare